Solomon Seeks $3.8M From Spirogen For AstraZeneca Deal
Investment banking advisory firm Peter J. Solomon Co. is suing a British biotech company, formerly known as Spirogen Ltd., seeking $3.75 million in fees for advising the company in its $200...To view the full article, register now.
Already a subscriber? Click here to view full article